Back to CVE records
Medium 4.3Published Oct 19, 2026

CVE-2026-112093subhajitkhan online-clinic-management-system feedback.php cross site scripting

Updated under an hour ago ()

Does this affect you?

It affects subhajitkhan online-clinic-management-system. Add what you run to find out whether that includes you.

No exploitation reported and no EPSS estimate yet.

A vulnerability has been found in subhajitkhan online-clinic-management-system up to e9ee77a8827a1446220fa07ee693dc4d9a29a578. The impacted element is an unknown function of the file feedback.php. The manipulation of the argument msg leads to cross site scripting. The attack can be initiated remotely. The exploit has been disclosed to the public and may be used. Continious delivery with rolling releases is used by this product. Therefore, no version details of affected nor updated releases are available. The project was informed of the problem early through an issue report but has not responded yet.

CVSS
4.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:N/I:L/A:N/E:P/RL:X/RC:C
Weakness (CWE)
CWE-79, CWE-94
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
VulDB
NVD analysis
Received
Record last updated
Oct 19, 2026
First seen by InfoSec Signals
Oct 19, 2026

Affected products

Affected products
subhajitkhan online-clinic-management-system
subhajitkhan:online-clinic-management-system
e9ee77a8827a1446220fa07ee693dc4d9a29a578
CNA record

References

  • vdb-entry, technical-description
  • signature, permissions-required
  • third-party-advisory
  • third-party-advisory
  • exploit, issue-tracking
  • product

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.